How Do Emerging Therapies Challenge Existing Regulatory Frameworks?
Emerging therapies, such as immunotherapies and gene editing technologies, present new challenges for regulatory bodies. These innovative treatments often involve complex mechanisms of action and may require new evaluation criteria. Regulatory agencies are continually adapting their frameworks to keep pace with scientific advancements.
